About the job
ABOUT US
With over 9 million immunocompromised individuals in the United States, a significant portion faces high risks from severe COVID-19. At Invivyd, we are dedicated to safeguarding these vulnerable populations, including stem cell and solid organ transplant patients and those battling hematologic cancers.
Our mission is to innovate and provide protection against serious viral infections, starting with SARS-CoV-2. Utilizing our proprietary integrated technology platform, we develop, assess, and adapt to create top-tier antibodies.
Recent Milestones:
In March 2024, we received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody in our innovative pipeline. Following this, in October 2025, the FDA approved our Investigational New Drug (IND) application, enabling us to advance our REVOLUTION clinical program for VYD2311, a monoclonal antibody being explored as a vaccine alternative for COVID-19 prevention.
Join us in making a meaningful impact. Be part of Invivyd.
Position Summary:
Invivyd is pioneering a new realm in infectious disease prevention. With an authorized product currently available, a promising Phase 3 program, and a robust pipeline, we are poised for significant growth.
We are seeking a Strategic Account Manager who will be instrumental in our journey. This role is perfect for individuals who are passionate about improving patient outcomes, implementing effective sales strategies, and fostering an adaptable and compliant culture. You will oversee strategic territory planning, nurture valuable partnerships with key accounts, and provide compliant, clear education on approved messaging to diverse healthcare stakeholders.

